Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: December 3, 2022

Details for Patent: 10,028,965

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Which drugs does patent 10,028,965 protect, and when does it expire?

Patent 10,028,965 protects DEXYCU KIT and is included in one NDA.

This patent has eleven patent family members in eight countries.

Summary for Patent: 10,028,965
Title:Use of sustained release dexamethasone in post-cataract surgery inflammation
Abstract: The present embodiments provide for a treatment regimen and use of a short-term sustained release liquid formulation of dexamethasone in citrate, wherein a single administration of a minute dosage form into the anterior chamber of the eye provides for anti-inflammatory therapy following cataract surgery.
Inventor(s): Wong; Vernon G. (Menlo Park, CA), White; William S. (Birmingham, AL), Hu; Mae W. (Los Altos Hills, CA), Huang; Glenn T. (Fremont, CA), Karasina; Faina (Mountain View, CA)
Assignee: ICON BIOSCIENCE, INC. (Newark, CA)
Application Number:14/893,381
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 10,028,965

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing TREATMENT OF POSTOPERATIVE INFLAMMATION See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,028,965

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014268434 See Plans and Pricing
Canada 2913336 See Plans and Pricing
China 105407896 See Plans and Pricing
China 110339153 See Plans and Pricing
European Patent Office 3003318 See Plans and Pricing
Spain 2902951 See Plans and Pricing
Japan 2016526039 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.